Eye Health

Drivers with Glaucoma at an increased risk for Car Accidents

Street traffic - BSN

(Best Syndication News) - A study conducted in Japan found that people with glaucoma had around twice as many accidents compared to a person with normal vision when using a driving simulator. The study results were presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, which this year has been joined with the Asia-Pacific Academy of Ophthalmology.

Around 2.7 million Americans over the age 40 have glaucoma. Many people may not be aware that they have the disease because the vision loss is gradual and painless. Left untreated, the person can become blind. First they lose peripheral vision, but eventually the optic nerve can become damaged.

Smoking Cigarettes may increase risk for Cataracts

Man walking - BSN

(Best Syndication News) - A study from China found that smoking cigarettes increases a person’s risk for developing age-related cataracts. The study, “Smoking and Risk of Age-related Cataract: A Meta-analysis,” was published in journal of Ophthalmology & Visual Science.

The researchers conducted a meta-analysis to determine the associated risk of smoking and age-related cataracts. They investigated 12 cohorts and 8 case-control studies conducted in Africa, Asia, Australia, Europe, and North America. They compared the rate of age-related cataracts in people who ever smoked cigarettes in their lifetime to those who never smoked. The researchers also evaluated if they were a current or a past smoker, and the three subtypes of age-related cataracts.

'Koff & Kold' and 'Kold Sore' sprays recalled for Safety Concerns

nose - BSN

(Best Syndication News) - The US Food and Drug Administration announced the recall of Wholistic Herbs Inc.’s “Koff & Kold” and “Kold Sore” spray products because they have not been properly tested for safety. There is a danger of the products being non-sterile, which could cause infections in the eyes or nose. The eye product could cause vision loss in some cases.

The Kold Sore product is used for the eyes to treat dry eye or pink eye, while the Koff & Kold product is used in the nose and throat for treatments of colds, flu, cough, stuffy nose, or a sinus infection.

The FDA found several labeling problems with the products during a routine inspection.

Nearsightedness Myopia Gene discovered could lead to New Treatments

Nearsightedness Myopia Gene discovered could lead to New Treatments

Best Syndication News

(Best Syndication News) - Having to wear glasses to see better might become obsolete because researchers have found a gene that is associated with nearsightedness. Developing gene therapies could treat the vision problem suggests scientists. In nearsightedness, a person can see near but will have blurry vision when looking at far distances. The researchers reported their findings about the genes related to myopia vision loss in the online September 12th Nature Genetics publication.

Researchers found that Caucasian from Dutch, British and Australian regions had a specific gene that were related to developing nearsightedness or myopia. Most cases of myopia is mild, but in some severe cases it can lead to blindness. Lead author Terri Young, M.D., professor of ophthalmology, pediatrics, and medicine, and a researcher in the Center for Human Genetics at Duke said that the eye is a good candidate for developing gene therapies because of the small contained area. The gene therapy would be easier to retain in the eye area and would also be easier to study results in an noninvasive way.

Diabetic Retinopathy – Two Therapies could slow down Eye Disease Blindness

Diabetic Retinopathy – Two Therapies could slow down Eye Disease Blindness

see video below

(Best Syndication News) - The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, which was funded in part by the National Institutes of Health, have found two therapies that might slow down the progression of diabetic retinopathy. This eye disease is the most common reason for working adults to go blind or having significant vision loss in America. The study results were published in the June 29th online edition of the New England Journal of Medicine (NEJM) and will also be presented at the 70th Scientific Sessions of the American Diabetes Association.

The ACCORD study included 10,251 adults with type 2 diabetes who were at especially high risk for heart attack, stroke or cardiovascular death. The study looked into three different intensive treatment plans that were being tested to lower the risk for cardiovascular risk factors caused by diabetes. They had a subgroup involved in the Eye Study which included 2,856 participants from the ACCORD study which they documented the diabetic retinopathy progression over a four year time period.

Syndicate content


Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved